Skip to main content
. 2022 Nov 28;32(3):e1954. doi: 10.1002/mpr.1954

TABLE 6.

Self‐harm, suicidal behavior, psychotic‐like symptoms, alcohol and substance use in overall cohort and in male, female, and nonbinary participants

Total Male Female Nonbinary
Ever self‐harmed, n (%) N = 6373 n = 2963 n = 3118 n = 117
Never 4966 (77.9) 2528 (85.3) 2311 (74.1) 48 (41.0)
Once 654 (10.3) 244 (8.2) 372 (11.9) 14 (12.0)
2, 3 or 4 times 403 (6.3) 115 (3.9) 241 (7.7) 24 (20.5)
5 or more times 350 (5.5) 76 (2.6) 194 (6.2) 31 (26.5)
Suicidal behavior in past 12 months, n (%) N = 6370 n = 2960 n = 3118 n = 117
Suicidal ideation 499 (7.8) 159 (5.4) 277 (8.9) 29 (24.8)
Suicide plan 413 (6.5) 135 (4.6) 230 (7.4) 27 (23.1)
Suicide attempt 307 (4.8) 99 (3.3) 169 (5.4) 19 (16.9)
Psychotic‐like symptoms, n (%) N = 6163 n = 2832 n = 3047 n = 114
Paranoia 778 (12.8) 176 (6.2) 516 (16.9) 45 (39.5)
Auditory hallucinations 1039 (16.9) 317 (11.2) 607 (19.9) 53 (46.5)
Visual hallucinations 808 (13.1) 276 (9.7) 449 (14.7) 33 (28.9)
Alcohol use, n (%) n = 6161 n = 2831 n = 3046 n = 114
Ever had standard drink 860 (14.0) 427 (15.1) 381 (12.5) 24 (21.1)
Standard drink in past 6 months 634 (10.3) 313 (11.0) 289 (9.5) 13 (11.4)
Ever had 5+ standard drinks 211 (3.4) 108 (3.8) 93 (3.1) <5 (<5)
Substance use in past 6 months, n (%) N = 6156 n = 2830 n = 3042 n = 114
No drug use 5333 (86.6) 2430 (85.9) 2664 (87.6) 98 (86.0)
Cannabis 140 (2.3) 104 (3.7) 83 (2.7) 9 (7.9)
Tobacco 215 (3.5) 104 (3.7) 88 (2.9) 10 (8.8)
Amphetamines 18 (0.3) 9 (0.3) <5 (<1) <5 (<5)
Ecstasy 33 (0.5) 14 (0.5) 13 (0.4) <5 (<5)
Hallucinogens 30 (0.5) 13 (0.5) 12 (0.4) <5 (<5)
Sedatives 26 (0.4) 11 (0.4) 12 (0.4) <5 (<5)
Inhalants 45 (0.7) 20 (0.7) 20 (0.7) <5 (<5)
Other substance/s 249 (4.0) 93 (3.3) 139 (4.6) 7 (6.1)

Note: Data are n and %. To protect the identities of individuals, values less than 5 are censored and reported as ‘<5'. Data are presented by gender identity.